Literature DB >> 33547588

Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.

Catherine M Cahill1,2,3,4, Lindsay Lueptow5,6,7, Hannah Kim6, Raj Shusharla6, Amy Bishop6, Christopher J Evans5,6,8,9,7.   

Abstract

Pain is complex and is a unique experience for individuals in that no two people will have exactly the same physiological and emotional response to the same noxious stimulus or injury. Pain is composed of two essential processes: a sensory component that allows for discrimination of the intensity and location of a painful stimulus and an emotional component that underlies the affective, motivational, unpleasant, and aversive response to a painful stimulus. Kappa opioid receptor (KOR) activation in the periphery and throughout the neuroaxis modulates both of these components of the pain experience. In this chapter we focus on recent findings that KORs contribute to the emotional, aversive nature of chronic pain, including how expression in the limbic circuitry contributes to anhedonic states and components of opioid misuse disorder. While the primary focus is on preclinical pain models, we also highlight clinical or human research where there is strong evidence for KOR involvement in negative affective states associated with chronic pain and opioid misuse.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Amygdala; Analgesia; Anhedonia; Antinociception; Biased agonist; Chronic pain; Dopamine; Dynorphin; Emotional component of pain; Endogenous opioid; Inflammatory pain; Kappa opioid receptor; Mesolimbic circuitry; Negative affect; Neuropathic pain; Nociception; Nucleus accumbens; Opioid misuse; Opioid use disorder; Pain; Pain aversion; Peripherally-restricted; Ventral tegmental area

Mesh:

Substances:

Year:  2022        PMID: 33547588      PMCID: PMC9436635          DOI: 10.1007/164_2021_434

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  205 in total

1.  Opioid peptide immunoreactivity in spinal and trigeminal dorsal horn neurons projecting to the parabrachial nucleus in the rat.

Authors:  D G Standaert; S J Watson; R A Houghten; C B Saper
Journal:  J Neurosci       Date:  1986-05       Impact factor: 6.167

2.  Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization.

Authors:  M J Iadarola; J Douglass; O Civelli; J R Naranjo
Journal:  Brain Res       Date:  1988-07-12       Impact factor: 3.252

Review 3.  The role of the periaqueductal gray in escape behavior.

Authors:  Yaara Lefler; Dario Campagner; Tiago Branco
Journal:  Curr Opin Neurobiol       Date:  2019-12-19       Impact factor: 6.627

4.  Role of κ-Opioid Receptors in the Bed Nucleus of Stria Terminalis in Reinstatement of Alcohol Seeking.

Authors:  A D Lê; Douglas Funk; Kathleen Coen; Sahar Tamadon; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2017-06-07       Impact factor: 7.853

Review 5.  Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.

Authors:  Elyssa B Margolis; Anushree N Karkhanis
Journal:  Neurochem Int       Date:  2019-07-10       Impact factor: 3.921

6.  Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters.

Authors:  Barbara Stanley; Leo Sher; Scott Wilson; Rolf Ekman; Yung-yu Huang; J John Mann
Journal:  J Affect Disord       Date:  2009-11-25       Impact factor: 4.839

7.  Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.

Authors:  T S Shippenberg; R Bals-Kubik; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

8.  Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.

Authors:  S S Negus; S J Henriksen; A Mattox; G W Pasternak; P S Portoghese; A E Takemori; M B Weinger; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

9.  General anesthetics activate a potent central pain-suppression circuit in the amygdala.

Authors:  Thuy Hua; Bin Chen; Dongye Lu; Katsuyasu Sakurai; Shengli Zhao; Bao-Xia Han; Jiwoo Kim; Luping Yin; Yong Chen; Jinghao Lu; Fan Wang
Journal:  Nat Neurosci       Date:  2020-05-18       Impact factor: 24.884

10.  Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.

Authors:  Douglas Funk; Kathleen Coen; Sahar Tamadon; A D Lê
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

View more
  2 in total

1.  (-)-Naringenin 4',7-dimethyl Ether Isolated from Nardostachys jatamansi Relieves Pain through Inhibition of Multiple Channels.

Authors:  Ru-Rong Gu; Xian-Hua Meng; Yin Zhang; Hai-Yan Xu; Li Zhan; Zhao-Bing Gao; Jun-Li Yang; Yue-Ming Zheng
Journal:  Molecules       Date:  2022-03-07       Impact factor: 4.411

2.  Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.

Authors:  Courtney M Cameron; Steven Nieto; Lucienne Bosler; Megan Wong; Isabel Bishop; Larissa Mooney; Catherine M Cahill
Journal:  Adv Drug Alcohol Res       Date:  2021-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.